Nutra Pharma Corp.
Bringing Healthcare Solutions to the World
 
Contact
Contact
Drug Development
R&D Pipeline
Nutra Pharma is developing an innovative pipeline of biopharmaceutical products
E-Alerts
Signup to receive news and announcements from Nutra Pharma:
First Name:
Last Name:
Email:
Infinite Menus, Copyright 2006, OpenCube Inc. All Rights Reserved.

Contact

We welcome all correspondence from those interested in our company, products, and research.

Mailing Address
Nutra Pharma Corporation
12502 W. Atlantic Blvd
Coral Springs, FL 33071 USA
 

Office: (954) 509-0911
Fax: (877) 895-5647

Attention Shareholders
Due to SEC Regulation Fair Disclosure, we cannot communicate individually with shareholders. For answers to basic shareholder questions pertaining to the location of historical factual information contained within the Company’s past press releases and/or the Company’s website, you may email investor.relations@nutrapharma.com.

Please note: We cannot address any questions pertaining to corporate financial information, including, but not limited to, past, present or future stock performance.

 
Quick Nav
Nyloxin // Chronic Pain Relief
Read about Jeff Gottfurcht, the first rheumatoid arthritis sufferer to conquer Everest, in Musculoskeletal Health a special section of the Washington Post.
 

 

 
Recent News
 
July 15, 2015
Nutra Pharma Announces the Submission of Their First Orphan Drug Application to the US Food and Drug Administration (FDA)


July 10, 2015
SeeThruEquity Initiates Coverage on Nutra Pharma Corporation with a Price Target of $0.53


June 30, 2015
Nutra Pharma Announces Engagement of Investment Banking Firm Pickwick Capital Partners to Provide Strategic Advisory Services


 
 
Announcements
Click here to view a Letter to Shareholders from the Company's CEO, Rik J Deitsch.
 
 
Facebook   Twitter
 
NPC
Privacy Policy Code of Ethics